Nuance Investments LLC Has $412.98 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nuance Investments LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 30.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,603,889 shares of the medical instruments supplier's stock after purchasing an additional 2,702,457 shares during the period. DENTSPLY SIRONA comprises about 9.4% of Nuance Investments LLC's portfolio, making the stock its 2nd largest holding. Nuance Investments LLC owned 5.48% of DENTSPLY SIRONA worth $412,982,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Bar Harbor Wealth Management bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $4,931,000. DAVENPORT & Co LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $1,220,000. Andra AP fonden grew its position in shares of DENTSPLY SIRONA by 20.3% in the 3rd quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier's stock valued at $10,340,000 after acquiring an additional 51,100 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of DENTSPLY SIRONA by 98.1% during the 3rd quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier's stock worth $11,861,000 after buying an additional 171,958 shares during the period. Finally, Mirabella Financial Services LLP bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth about $802,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.31 during midday trading on Friday, hitting $27.89. 7,071,708 shares of the company traded hands, compared to its average volume of 3,055,453. The stock has a market cap of $5.79 billion, a price-to-earnings ratio of -63.38, a PEG ratio of 1.22 and a beta of 1.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The firm's fifty day moving average price is $31.60 and its 200-day moving average price is $32.57. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts' consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the previous year, the firm posted $0.39 EPS. The company's revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.29%. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is presently -145.45%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Leerink Partnrs reiterated an "outperform" rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Piper Sandler restated a "neutral" rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an "outperform" rating for the company in a research report on Friday, May 3rd. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an "outperform" rating and a $42.00 target price for the company. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of "Moderate Buy" and an average target price of $35.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.